• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型α-2肾上腺素能受体拮抗剂YNS-15P对大鼠应激刺激结肠推进的影响。

Effect of YNS-15P, a new alpha-2 adrenoceptor antagonist, on stress-stimulated colonic propulsion in rats.

作者信息

Yamamoto O, Niida H, Tajima K, Shirouchi Y, Kyotani Y, Ueda F, Kise M, Kimura K

机构信息

Discovery Research Laboratories II, Nippon Shinyaku Co. Ltd., Kyoto, Japan.

出版信息

J Pharmacol Exp Ther. 1998 Nov;287(2):691-6.

PMID:9808698
Abstract

We studied effects of a novel alpha-2 adrenoceptor antagonist, YNS-15P (N-[(2R,11bS)-9-methoxy-1,3,4,6,7, 11b-hexahydro-2H-benzoquinolizin-2-yl]-N-methylmethanesulfonami de hydrochloride), on colonic propulsion stimulated by wrap-restraint stress (WRS) or bethanechol, on normal colonic propulsion and on diarrhea induced by castor oil in rats. Alpha-2 adrenoceptor antagonists, rauwolscine and RX821002, decreased the increase in the number and weight of fecal pellets induced by WRS. YNS-15P also inhibited WRS-stimulated fecal excretion in a dose-dependent manner. A 5-hydroxytryptamine3 receptor antagonist, granisetron, trimebutine and diazepam, but not a 5-hydroxytryptamine4 receptor antagonist, GR113808, significantly inhibited WRS-stimulated fecal excretion. YNS-15P inhibited WRS-stimulated colonic transit in a dose-dependent manner. However, YNS-15P had no significant effect on normal fecal excretion and colonic transit or on bethanechol-stimulated fecal excretion. YNS-15P also failed to inhibit castor-oil-induced diarrhea. These results indicate that YNS-15P selectively inhibits WRS-stimulated colonic propulsion, and that alpha-2 adrenoceptors may be involved in stress-induced colonic motor dysfunction in fed rats.

摘要

我们研究了一种新型α-2肾上腺素能受体拮抗剂YNS-15P(N-[(2R,11bS)-9-甲氧基-1,3,4,6,7,11b-六氢-2H-苯并喹嗪-2-基]-N-甲基甲磺酰胺盐酸盐)对束缚应激(WRS)或氨甲酰甲胆碱刺激的结肠推进、正常结肠推进以及蓖麻油诱导的大鼠腹泻的影响。α-2肾上腺素能受体拮抗剂萝芙辛和RX821002可减少WRS诱导的粪便颗粒数量和重量的增加。YNS-15P也以剂量依赖的方式抑制WRS刺激的粪便排泄。5-羟色胺3受体拮抗剂格拉司琼、曲美布汀和地西泮可显著抑制WRS刺激的粪便排泄,但5-羟色胺4受体拮抗剂GR113808则无此作用。YNS-15P以剂量依赖的方式抑制WRS刺激的结肠转运。然而,YNS-15P对正常粪便排泄和结肠转运或氨甲酰甲胆碱刺激的粪便排泄无显著影响。YNS-15P也未能抑制蓖麻油诱导的腹泻。这些结果表明,YNS-15P选择性抑制WRS刺激的结肠推进,且α-2肾上腺素能受体可能参与了进食大鼠应激诱导的结肠运动功能障碍。

相似文献

1
Effect of YNS-15P, a new alpha-2 adrenoceptor antagonist, on stress-stimulated colonic propulsion in rats.新型α-2肾上腺素能受体拮抗剂YNS-15P对大鼠应激刺激结肠推进的影响。
J Pharmacol Exp Ther. 1998 Nov;287(2):691-6.
2
Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo.强效5-羟色胺3和5-羟色胺4受体双重拮抗剂FK1052对体内结肠功能的影响。
J Pharmacol Exp Ther. 1993 Jul;266(1):74-80.
3
Inhibition of stress-stimulated colonic propulsion by alpha 2-adrenoceptor antagonists in rats.
Neurogastroenterol Motil. 1998 Dec;10(6):523-32. doi: 10.1046/j.1365-2982.1998.00127.x.
4
Effect of alpha-2 adrenoceptor antagonists on colonic function in rats.α-2肾上腺素能受体拮抗剂对大鼠结肠功能的影响。
Neurogastroenterol Motil. 2000 Jun;12(3):249-55. doi: 10.1046/j.1365-2982.2000.00206.x.
5
Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats.雷莫司琼对以条件性情绪应激诱导的结肠功能障碍作为大鼠肠易激综合征模型的影响。
Eur J Pharmacol. 2007 Nov 14;573(1-3):190-5. doi: 10.1016/j.ejphar.2007.06.041. Epub 2007 Jul 3.
6
5-HT3 receptor antagonists. 3. Quinoline derivatives which may be effective in the therapy of irritable bowel syndrome.5-羟色胺3受体拮抗剂。3. 可能对治疗肠易激综合征有效的喹啉衍生物。
J Med Chem. 1993 Oct 29;36(22):3286-92. doi: 10.1021/jm00074a009.
7
Effect of GK-128 [2-[(2-methylimidazol-1-yl)methyl]-benzo[f]thiochromen-1-one monohydrochloride hemihydrate], a selective 5-hydroxytryptamine3 receptor antagonist, on colonic function in rats.选择性5-羟色胺3受体拮抗剂GK-128[2-[(2-甲基咪唑-1-基)甲基]-苯并[f]硫代色烯-1-酮盐酸盐半水合物]对大鼠结肠功能的影响。
J Pharmacol Exp Ther. 1997 Jan;280(1):67-72.
8
Wood creosote prevents CRF-induced motility via 5-HT3 receptors in proximal and 5-HT4 receptors in distal colon in rats.木馏油通过大鼠近端结肠的5-羟色胺3型受体和远端结肠的5-羟色胺4型受体来阻止慢性肾功能衰竭引起的运动。
Auton Neurosci. 2007 May 30;133(2):136-45. doi: 10.1016/j.autneu.2006.11.002. Epub 2006 Dec 19.
9
Effects of serotonin 5-HT3 receptor antagonists on stress-induced colonic hyperalgesia and diarrhoea in rats: a comparative study with opioid receptor agonists, a muscarinic receptor antagonist and a synthetic polymer.血清素5-HT3受体拮抗剂对大鼠应激诱导的结肠痛觉过敏和腹泻的影响:与阿片受体激动剂、毒蕈碱受体拮抗剂及合成聚合物的对比研究
Neurogastroenterol Motil. 2008 May;20(5):557-65. doi: 10.1111/j.1365-2982.2007.01069.x. Epub 2008 Jan 21.
10
Restraint stress stimulates colonic motility via central corticotropin-releasing factor and peripheral 5-HT3 receptors in conscious rats.束缚应激通过中枢促肾上腺皮质激素释放因子和外周5-羟色胺3受体刺激清醒大鼠的结肠运动。
Am J Physiol Gastrointest Liver Physiol. 2007 Apr;292(4):G1037-44. doi: 10.1152/ajpgi.00419.2006. Epub 2006 Dec 7.

引用本文的文献

1
Aminophylline suppresses stress-induced visceral hypersensitivity and defecation in irritable bowel syndrome.氨茶碱抑制肠易激综合征应激诱导的内脏敏感性和排便。
Sci Rep. 2017 Jan 5;7:40214. doi: 10.1038/srep40214.
2
Regulatory mechanism of electroacupuncture in irritable bowel syndrome: preventing MC activation and decreasing SP VIP secretion.电针治疗肠易激综合征的调节机制:预防肥大细胞激活并减少P物质和血管活性肠肽分泌。
Dig Dis Sci. 2008 Jun;53(6):1644-51. doi: 10.1007/s10620-007-0062-4.
3
L-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats.
L-赖氨酸的作用类似于部分5-羟色胺受体4拮抗剂,可抑制5-羟色胺介导的大鼠肠道病变和焦虑。
Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15370-5. doi: 10.1073/pnas.2436556100. Epub 2003 Dec 15.
4
Effect of psychogenic stress on gastrointestinal function.心理性应激对胃肠功能的影响。
J Physiol Biochem. 2000 Sep;56(3):259-74. doi: 10.1007/BF03179794.
5
Increased defecation during stress or after 5-hydroxytryptophan: selective inhibition by the 5-HT(4) receptor antagonist, SB-207266.应激期间或给予5-羟色氨酸后排便增加:5-HT(4)受体拮抗剂SB-207266的选择性抑制作用
Br J Pharmacol. 2000 Jun;130(3):706-12. doi: 10.1038/sj.bjp.0703367.